Global Icodec Insulin Market Growth 2024-2030

Publication ID:

LPI07248018

Publication Date:

July 24, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Icodec Insulin is a long-acting insulin analog that is widely used in basal insulin therapy for patients with type 1 and type 2 diabetes. Its structure has been modified so that it forms microcrystals after subcutaneous injection, gradually releasing insulin and providing stable blood sugar control for up to 24 hours. This long-acting property reduces the risk of hypoglycemia, especially the incidence of nocturnal hypoglycemia. Icodec Insulin usually only needs to be injected once a day, and its stable efficacy can maintain blood sugar balance throughout the day regardless of when it is injected.
The global Icodec Insulin market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the 鈥淚codec Insulin Industry Forecast鈥� looks at past sales and reviews total world Icodec Insulin sales in 2023, providing a comprehensive analysis by region and market sector of projected Icodec Insulin sales for 2024 through 2030. With Icodec Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Icodec Insulin industry.
This Insight Report provides a comprehensive analysis of the global Icodec Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Icodec Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Icodec Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Icodec Insulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Icodec Insulin.
United States market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Icodec Insulin players cover Novo Nordisk, Lilly, Sanofi, Paijin Biotechnology, Gan&Lee Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Icodec Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Long-acting
Medium-acting
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
Lilly
Sanofi
Paijin Biotechnology
Gan&Lee Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Icodec Insulin market?
What factors are driving Icodec Insulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Icodec Insulin market opportunities vary by end market size?
How does Icodec Insulin break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Icodec Insulin Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Icodec Insulin by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Icodec Insulin by Country/Region, 2019, 2023 & 2030
2.2 Icodec Insulin Segment by Type
2.2.1 Long-acting
2.2.2 Medium-acting
2.3 Icodec Insulin Sales by Type
2.3.1 Global Icodec Insulin Sales Market Share by Type (2019-2024)
2.3.2 Global Icodec Insulin Revenue and Market Share by Type (2019-2024)
2.3.3 Global Icodec Insulin Sale Price by Type (2019-2024)
2.4 Icodec Insulin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Icodec Insulin Sales by Application
2.5.1 Global Icodec Insulin Sale Market Share by Application (2019-2024)
2.5.2 Global Icodec Insulin Revenue and Market Share by Application (2019-2024)
2.5.3 Global Icodec Insulin Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Icodec Insulin Breakdown Data by Company
3.1.1 Global Icodec Insulin Annual Sales by Company (2019-2024)
3.1.2 Global Icodec Insulin Sales Market Share by Company (2019-2024)
3.2 Global Icodec Insulin Annual Revenue by Company (2019-2024)
3.2.1 Global Icodec Insulin Revenue by Company (2019-2024)
3.2.2 Global Icodec Insulin Revenue Market Share by Company (2019-2024)
3.3 Global Icodec Insulin Sale Price by Company
3.4 Key Manufacturers Icodec Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Icodec Insulin Product Location Distribution
3.4.2 Players Icodec Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Icodec Insulin by Geographic Region
4.1 World Historic Icodec Insulin Market Size by Geographic Region (2019-2024)
4.1.1 Global Icodec Insulin Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Icodec Insulin Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Icodec Insulin Market Size by Country/Region (2019-2024)
4.2.1 Global Icodec Insulin Annual Sales by Country/Region (2019-2024)
4.2.2 Global Icodec Insulin Annual Revenue by Country/Region (2019-2024)
4.3 Americas Icodec Insulin Sales Growth
4.4 APAC Icodec Insulin Sales Growth
4.5 Europe Icodec Insulin Sales Growth
4.6 Middle East & Africa Icodec Insulin Sales Growth
5 Americas
5.1 Americas Icodec Insulin Sales by Country
5.1.1 Americas Icodec Insulin Sales by Country (2019-2024)
5.1.2 Americas Icodec Insulin Revenue by Country (2019-2024)
5.2 Americas Icodec Insulin Sales by Type (2019-2024)
5.3 Americas Icodec Insulin Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Icodec Insulin Sales by Region
6.1.1 APAC Icodec Insulin Sales by Region (2019-2024)
6.1.2 APAC Icodec Insulin Revenue by Region (2019-2024)
6.2 APAC Icodec Insulin Sales by Type (2019-2024)
6.3 APAC Icodec Insulin Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Icodec Insulin by Country
7.1.1 Europe Icodec Insulin Sales by Country (2019-2024)
7.1.2 Europe Icodec Insulin Revenue by Country (2019-2024)
7.2 Europe Icodec Insulin Sales by Type (2019-2024)
7.3 Europe Icodec Insulin Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Icodec Insulin by Country
8.1.1 Middle East & Africa Icodec Insulin Sales by Country (2019-2024)
8.1.2 Middle East & Africa Icodec Insulin Revenue by Country (2019-2024)
8.2 Middle East & Africa Icodec Insulin Sales by Type (2019-2024)
8.3 Middle East & Africa Icodec Insulin Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Icodec Insulin
10.3 Manufacturing Process Analysis of Icodec Insulin
10.4 Industry Chain Structure of Icodec Insulin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Icodec Insulin Distributors
11.3 Icodec Insulin Customer
12 World Forecast Review for Icodec Insulin by Geographic Region
12.1 Global Icodec Insulin Market Size Forecast by Region
12.1.1 Global Icodec Insulin Forecast by Region (2025-2030)
12.1.2 Global Icodec Insulin Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Icodec Insulin Forecast by Type (2025-2030)
12.7 Global Icodec Insulin Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Icodec Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Lilly
13.2.1 Lilly Company Information
13.2.2 Lilly Icodec Insulin Product Portfolios and Specifications
13.2.3 Lilly Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lilly Main Business Overview
13.2.5 Lilly Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Icodec Insulin Product Portfolios and Specifications
13.3.3 Sanofi Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Paijin Biotechnology
13.4.1 Paijin Biotechnology Company Information
13.4.2 Paijin Biotechnology Icodec Insulin Product Portfolios and Specifications
13.4.3 Paijin Biotechnology Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Paijin Biotechnology Main Business Overview
13.4.5 Paijin Biotechnology Latest Developments
13.5 Gan&Lee Pharmaceuticals
13.5.1 Gan&Lee Pharmaceuticals Company Information
13.5.2 Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolios and Specifications
13.5.3 Gan&Lee Pharmaceuticals Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Gan&Lee Pharmaceuticals Main Business Overview
13.5.5 Gan&Lee Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂